Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion (Q44259838)

1 December 2017

title

Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion (English)

1 reference

1 December 2017

1 reference

Kasem Nithipatikom

1

1 reference

1 December 2017

Marilyn A Isbell

2

1 reference

1 December 2017

Paul F Lindholm

3

1 reference

1 December 2017

Andre Kajdacsy-Balla

4

1 reference

1 December 2017

Sushma Kaul

5

1 reference

1 December 2017

William B Campell

6

1 reference

1 December 2017

publication date

1 January 2002

1 reference

Clinical & Experimental Metastasis

1 December 2017

published in

1 reference

1 December 2017

volume

19

1 reference

1 December 2017

issue

7

1 reference

1 December 2017

page(s)

593-601

1 reference

Arachidonic acid metabolism in benign and malignant prostatic tissue in vitro: effects of fatty acids and cyclooxygenase inhibitors

1 December 2017

cites work

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Cytoplasmic induction and over-expression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: evidence for growth suppression by inhibiting COX-2 expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

PEA3 is up-regulated in response to Wnt1 and activates the expression of cyclooxygenase-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Inhibition of cyclooxygenase: a novel approach to cancer prevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Evidence for separate mechanisms of antiproliferative action of indomethacin and prostaglandin on MCF-7 breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

A new in vitro assay for quantitating tumor cell invasion

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Identification and characterization of a prostaglandin transporter

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

The cyclooxygenase isoforms: structural insights into the conversion of arachidonic acid to prostaglandins

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Prostaglandin transporter PGT is expressed in cell types that synthesize and release prostanoids

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Overview of articles on eicosanoids and cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Differential allosteric regulation of prostaglandin H synthase 1 and 2 by arachidonic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Indomethacin, a cox inhibitor, enhances 15-PGDH and decreases human tumoral C cells proliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase?

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

The role of constitutive NF-kappaB activity in PC-3 human prostate cancer cell invasive behavior

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Interactions of PGH synthase isozymes-1 and -2 with NSAIDs

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Prostaglandin E2 increases growth and motility of colorectal carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Effect of the nonsteroidal anti-inflammatory drug indomethacin on proliferation and apoptosis of colon carcinoma cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Expression of cyclooxygenase-2 in prostate carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Inhibition of tumor growth and metastasis by chronic intravenous infusion of prostaglandin E1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Regulation of proliferation of rat mammary tumor cells by inhibitors of cyclooxygenase and lipoxygenase

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Up-regulation of cyclooxygenase-2 by product-prostaglandin E2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Prostaglandin endoperoxide synthase: regulation of enzyme expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Mechanism of prostaglandin E2 transport across the plasma membrane of HeLa cells and Xenopus oocytes expressing the prostaglandin transporter "PGT".

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Yes, but do they still get headaches?

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

The effect of prostaglandin modulators on prostate tumor growth and metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Identification of arachidonic acid pathways required for the invasive and metastatic activity of malignant tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Cyclooxygenase-2: a novel target for cancer chemotherapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Indomethacin increases 15-PGDH mRNA expression in HL60 cells differentiated by PMA.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Nonsteroidal anti-inflammatory drugs attenuate epidermal growth factor-induced proliferation independent of prostaglandin synthesis inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Induction of NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase expression by androgens in human prostate cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Expression of PGT in MDCK cell monolayers: polarized apical localization and induction of active PG transport

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Cyclooxygenase and lipoxygenase inhibitors in cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Overexpression of cyclooxygenase-2 induces cell cycle arrest. Evidence for a prostaglandin-independent mechanism

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Cyclooxygenase-2 expression in colorectal cancer liver metastases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Establishment and characterization of a human lung cancer cell line NCI-H460-LNM35 with consistent lymphogenous metastasis via both subcutaneous and orthotopic propagation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

C-Terminal region of human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase is involved in the interaction with prostaglandin substrates

1 reference

https://pubmed.ncbi.nlm.nih.gov/12498388

12 December 2020

Identifiers

DOI

10.1023/A:1020915914376

1 reference

Dimensions Publication ID

1 December 2017

1032494148

0 references

1 reference